Know Cancer

or
forgot password
  • cancer clinical trials in troy, OH

  • Comparison of Combination Chemotherapy Regimens in Treating Older Women Who Have Undergone Surgery for Breast Cancer
    UVMC Cancer Care Center at Upper Valley Medical Center
    Troy, Ohio 45373-1300
    Breast Cancer
    Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer
    UVMC Cancer Care Center at Upper Valley Medical Center
    Troy, Ohio 45373-1300
    Breast Cancer
    Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
    UVMC Cancer Care Center at Upper Valley Medical Center
    Troy, Ohio 45373-1300
    Breast Cancer
    Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
    UVMC Cancer Care Center at Upper Valley Medical Center
    Troy, Ohio 45373-1300
    Lymphoma
    4B951, Combination Chemotherapy in Treating Patients With Bladder Cancer
    UVMC Cancer Care Center at Upper Valley Medical Center
    Troy, Ohio 45373-1300
    Bladder Cancer
    S0016 Combination Chemotherapy With Monoclonal Antibody Therapy in Treating Patients With Newly Diagnosed Non-Hodgkin's Lymphoma
    UVMC Cancer Care Center at Upper Valley Medical Center
    Troy, Ohio 45373-1300
    Lymphoma
    Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer
    UVMC Cancer Care Center at Upper Valley Medical Center
    Troy, Ohio 45373-1300
    Lung Cancer
    S0204 Thalidomide, Chemotherapy, and Peripheral Stem Cell Transplant in Treating Patients With Multiple Myeloma
    UVMC Cancer Care Center at Upper Valley Medical Center
    Troy, Ohio 45373-1300
    Multiple Myeloma
    Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer
    UVMC Cancer Care Center at Upper Valley Medical Center
    Troy, Ohio 45373-1300
    Breast Cancer
    Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer
    UVMC Cancer Care Center at Upper Valley Medical Center
    Troy, Ohio 45373-1300
    Esophageal Cancer, Gastric Cancer
    Combination Chemotherapy in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
    UVMC Cancer Care Center at Upper Valley Medical Center
    Troy, Ohio 45373-1300
    Endometrial Cancer
    Imatinib Mesylate or Dasatinib in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia
    Upper Valley Medical Center
    Troy, Ohio 45373
    Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Chronic Phase Chronic Myelogenous Leukemia
    S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer
    UVMC Cancer Care Center at Upper Valley Medical Center
    Troy, Ohio 45373-1300
    Breast Cancer
    Interferon Alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer)
    UVMC Cancer Care Center at Upper Valley Medical Center
    Troy, Ohio 45373-1300
    Kidney Cancer
    Rituximab in Treating Patients With Low Tumor Burden Indolent Non-Hodgkin's Lymphoma
    UVMC Cancer Care Center at Upper Valley Medical Center
    Troy, Ohio 45373-1300
    Lymphoma
    Creatine in Treating Patients With Cancer-Associated Weight Loss
    UVMC Cancer Care Center at Upper Valley Medical Center
    Troy, Ohio 45373-1300
    Anorexia, Cachexia, Unspecified Adult Solid Tumor, Protocol Specific, Weight Changes
    S0106 Cytarabine and Daunorubicin w/ or w/o Gemtuzumab Followed By HD Cytarabine and Either Gemtuzumab or Nothing in de Novo AML
    UVMC Cancer Care Center at Upper Valley Medical Center
    Troy, Ohio 45373-1300
    Leukemia
    Radiation Therapy, Temozolomide, and Irinotecan in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
    UVMC Cancer Care Center at Upper Valley Medical Center
    Troy, Ohio 45373-1300
    Brain and Central Nervous System Tumors
    CCI-779 and Rituximab in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
    Upper Valley Medical Center
    Troy, Ohio 45373
    Recurrent Mantle Cell Lymphoma
    Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
    UVMC Cancer Care Center at Upper Valley Medical Center
    Troy, Ohio 45373-1300
    Colorectal Cancer
    Quality of Life, Employment, and Informal Care Costs in Women Who Are Receiving Chemotherapy for Breast Cancer
    UVMC Cancer Care Center at Upper Valley Medical Center
    Troy, Ohio 45373-1300
    Breast Cancer
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    Upper Valley Medical Center
    Troy, Ohio 45373
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    S0353, Gemcitabine in Treating Patients With Recurrent Bladder Cancer That Has Not Responded to Previous Bacillus Calmette-Guerin
    UVMC Cancer Care Center at Upper Valley Medical Center
    Troy, Ohio 45373-1300
    Bladder Cancer
    Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    Upper Valley Medical Center
    Troy, Ohio 45373
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer
    Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
    UVMC Cancer Care Center at Upper Valley Medical Center
    Troy, Ohio 45373-1300
    Colorectal Cancer
    Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With Stage III or Stage IV Head and Neck Cancer
    UVMC Cancer Care Center at Upper Valley Medical Center
    Troy, Ohio 45373-1300
    Head and Neck Cancer
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    Upper Valley Medical Center
    Troy, Ohio 45373
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
    Upper Valley Medical Center
    Troy, Ohio 45373
    Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer
    Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
    Upper Valley Medical Center
    Troy, Ohio 45373
    Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    S0530 Cytarabine and Clofarabine in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
    UVMC Cancer Care Center at Upper Valley Medical Center
    Troy, Ohio 45373-1300
    Leukemia
    Zoledronate, Vitamin D, and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or Delaying Bone Problems in Patients With Bone Metastases From Prostate Cancer, Lung Cancer, or Breast Cancer
    UVMC Cancer Care Center at Upper Valley Medical Center
    Troy, Ohio 45373-1300
    Breast Cancer, Lung Cancer, Metastatic Cancer, Pain, Prostate Cancer
    S0536: Cetuximab, Paclitaxel, Carboplatin, and Bevacizumab in Treating Patients With Advanced Non-Small Cell Lung Cancer
    UVMC Cancer Care Center at Upper Valley Medical Center
    Troy, Ohio 45373-1300
    Lung Cancer
    Bevacizumab, Sorafenib Tosylate, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer
    Upper Valley Medical Center
    Troy, Ohio 45373
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer
    Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer
    UVMC Cancer Care Center at Upper Valley Medical Center
    Troy, Ohio 45373-1300
    Breast Cancer
    Intensity-Modulated Radiation Therapy, Fluorouracil, and Mitomycin C in Treating Patients With Invasive Anal Cancer
    UVMC Cancer Care Center at Upper Valley Medical Center
    Troy, Ohio 45373-1300
    Anal Cancer
    Bevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme or Gliosarcoma
    Upper Valley Medical Center
    Troy, Ohio 45373
    Adult Glioblastoma, Adult Gliosarcoma, Recurrent Adult Brain Tumor
    Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
    Upper Valley Medical Center
    Troy, Ohio 45373
    Male Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
    Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
    UVMC Cancer Care Center at Upper Valley Medical Center
    Troy, Ohio 45373-1300
    Neurotoxicity Syndromes, Pain, Peripheral Neuropathy, Unspecified Adult Solid Tumor, Protocol Specific
    Combination Chemotherapy and Paclitaxel Plus Trastuzumab in Treating Women With Palpable Breast Cancer That Can Be Removed by Surgery
    Upper Valley Medical Center
    Troy, Ohio 45373
    HER2-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer
    Early or Delayed Fludarabine and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia
    UVMC Cancer Care Center at Upper Valley Medical Center
    Troy, Ohio 45373-1300
    Leukemia
    Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
    UVMC Cancer Care Center at Upper Valley Medical Center
    Troy, Ohio 45373-1300
    Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Lymphoproliferative Disorder, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, Neurotoxicity, Pain, Unspecified Adult Solid Tumor, Protocol Specific
    Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
    UVMC Cancer Care Center at Upper Valley Medical Center
    Troy, Ohio 45373-1300
    Breast Cancer
    First-Line Chemotherapy and Trastuzumab With or Without Bevacizumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER-2/NEU
    Upper Valley Medical Center
    Troy, Ohio 45373
    HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer
    Bortezomib and Dexamethasone With or Without Lenalidomide in Treating Patients With Multiple Myeloma Previously Treated With Dexamethasone
    Upper Valley Medical Center
    Troy, Ohio 45373
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
    UVMC Cancer Care Center at Upper Valley Medical Center
    Troy, Ohio 45373-1300
    Brain and Central Nervous System Tumors
    Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
    Upper Valley Medical Center
    Troy, Ohio 45373
    Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Salivary Gland Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Salivary Gland Squamous Cell Carcinoma, Stage IV Salivary Gland Cancer, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Oropharynx, Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IV Verrucous Carcinoma of the Larynx, Stage IV Verrucous Carcinoma of the Oral Cavity, Tongue Cancer, Untreated Metastatic Squamous Neck Cancer With Occult Primary
    Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia
    Upper Valley Medical Center
    Troy, Ohio 45373
    B-cell Chronic Lymphocytic Leukemia, Stage I Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia, Stage III Chronic Lymphocytic Leukemia, Stage IV Chronic Lymphocytic Leukemia
    Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
    Upper Valley Medical Center
    Troy, Ohio 45373
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
    Upper Valley Medical Center
    Troy, Ohio 45373
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Azacitidine and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
    Upper Valley Medical Center
    Troy, Ohio 45373
    Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Erythroleukemia (M6a), Adult Pure Erythroid Leukemia (M6b), Secondary Acute Myeloid Leukemia, Untreated Adult Acute Myeloid Leukemia
    Capecitabine and Lapatinib With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB, Stage IIIC, or Stage IV Breast Cancer
    Upper Valley Medical Center
    Troy, Ohio 45373
    HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    S0713: Oxaliplatin, Capecitabine, Cetuximab, and RT Followed By Surgery in Pts W/Stage II or III Rectal Cancer
    UVMC Cancer Care Center at Upper Valley Medical Center
    Troy, Ohio 45373-1300
    Colorectal Cancer
    American Ginseng in Treating Patients With Fatigue Caused by Cancer
    UVMC Cancer Care Center at Upper Valley Medical Center
    Troy, Ohio 45373-1300
    Chronic Myeloproliferative Disorders, Fatigue, Leukemia, Lymphoma, Lymphoproliferative Disorder, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, Precancerous Condition, Unspecified Adult Solid Tumor, Protocol Specific
    Gemcitabine and Erlotinib Before and After Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
    UVMC Cancer Care Center at Upper Valley Medical Center
    Troy, Ohio 45373-1300
    Pancreatic Cancer
    Pemetrexed or Erlotinib as Second-Line Therapy in Treating Patients With Advanced Non-Small Cell Lung Cancer
    Upper Valley Medical Center
    Troy, Ohio 45373
    Recurrent Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    S0722: Everolimus in Treating Patients With Pleural Malignant Mesothelioma That Cannot Be Removed By Surgery
    UVMC Cancer Care Center at Upper Valley Medical Center
    Troy, Ohio 45373-1300
    Malignant Mesothelioma
    S0715: Acetyl-L-Carnitine in Preventing Neuropathy in Women With Stage I, Stage II, or Stage IIIA Breast Cancer Undergoing Chemotherapy
    UVMC Cancer Care Center at Upper Valley Medical Center
    Troy, Ohio 45373-1300
    Breast Cancer, Chemotherapeutic Agent Toxicity, Fatigue, Neuropathy, Neurotoxicity
    Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer
    Upper Valley Medical Center
    Troy, Ohio 45373
    Male Breast Cancer, Recurrent Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    S0809: Capecitabine, Gemcitabine, and RT in Patients w/Cholangiocarcinoma of the Gallbladder or Bile Duct
    UVMC Cancer Care Center at Upper Valley Medical Center
    Troy, Ohio 45373-1300
    Extrahepatic Bile Duct Cancer, Gallbladder Cancer
    S0720: Adjuvant Therapy Based on Gene Expression in Stage IA and IB Non-Small Cell Lung Cancer
    UVMC Cancer Care Center at Upper Valley Medical Center
    Troy, Ohio 45373-1300
    Lung Cancer